Clinical Trials Browser

Neoplasm Metastasis

Neoplasm Metastasis

Neoplasm Metastasis

Neoplasm Metastasis

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Neoplasm Metastasis

Neoplasm Metastasis, Osteosarcoma

Neoplasm Metastasis, Sarcoma

Neoplasm Metastasis, Thyroid Neoplasms

Neoplasm Metastasis, Sarcoma, Ewing

Neoplasm Metastasis, Sarcoma

Neoplasm Metastasis, Skin Neoplasms, Carcinoma, Merkel Cell

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Breast Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis

Neoplasm Metastasis, Pancreatic Neoplasms

Brain Neoplasms, Neoplasm Metastasis

Carcinoma, Transitional Cell, Neoplasm Metastasis

Breast Neoplasms, Neoplasm Metastasis

Urinary Bladder Neoplasms, Neoplasm Metastasis

Lung Neoplasms, Melanoma, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Neoplasm Metastasis, Neoplasms, Peritoneal Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis, Stomach Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Neoplasm Metastasis, Cholangiocarcinoma

Urinary Bladder Neoplasms, Neoplasm Metastasis

Neoplasm Metastasis

Neoplasm Metastasis

Brain Neoplasms, Glioblastoma, Neoplasm Metastasis, Meningeal Carcinomatosis

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Melanoma, Neoplasm Metastasis

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

Neoplasm Metastasis

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

Clinical Trials

Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial

Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Testing the Use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)

A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

REGO-SARC

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

A Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma

Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

TOMBOLA

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

CoC

Charlie-2

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Tivozanib + Enzalutamide in Adv Prostate Cancer

Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

METAREM

A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer

H3RAKLES

Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

A Study of Amivantamab in People With Esophagogastric Cancer

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)